Fundraising Fox

Eterna Therapeutics

NASDAQ: ERNA

Cambridge, US · Delaware corporation

Biotech

Founders & leadership

DC
Dorothy ClarkeExecutive Officer, Director
SG
Sandra GurrolaExecutive Officer
SL
Sanjeev LutherExecutive Officer, Director
ES
Erin S. EnrightDirector
KD
Kevin D'AmourChief Scientific Officer
RS
Roger SidhuChief Medical Officer
EM
Erich MohrDirector
CC
Charles CheringtonDirector
HJ
Howard J. FederoffChief Executive Officer and President
JS
Jay SialChief Administration Officer
DL
Dennis LangerDirector
HB
Heather B. RedmanDirector

Reported raises · per SEC filings

Form D private placements
▶$7.2MraisedApr 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter CicalaDirector
  • Sandra GurrolaExecutive Officer
  • William WexlerDirector
  • James BristolDirector
  • Sanjeev LutherExecutive Officer, Director
  • Elena RatnerDirector
Offering amount
$7.2M
Amount sold
$7.2M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedNov 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dorothy ClarkeExecutive Officer, Director
  • Sanjeev LutherExecutive Officer, Director
  • William WexlerDirector
  • Sandra GurrolaExecutive Officer
  • James BristolDirector
  • Peter CicalaDirector
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedNov 2024 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dorothy ClarkeExecutive Officer, Director
  • William WexlerDirector
  • Sandra GurrolaExecutive Officer
  • Sanjeev LutherExecutive Officer, Director
  • James BristolDirector
  • Peter CicalaDirector
Offering amount
$3.9M
Amount sold
$3.9M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedDec 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James BristolDirector
  • William WexlerDirector
  • Matthew AngelExecutive Officer
  • Dorothy ClarkeDirector
  • Sandra GurrolaExecutive Officer
Offering amount
$9.2M
Amount sold
$7.8M
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.7MraisedJul 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandra GurrolaExecutive Officer
  • Brant BinderDirector
  • Richard W. WagnerDirector
  • Gregory FioreDirector
  • Matthew AngelExecutive Officer, Director
  • William WexlerDirector
Offering amount
$8.7M
Amount sold
$8.7M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.7MraisedJul 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew AngelExecutive Officer, Director
  • Gregory FioreDirector
  • Brant BinderDirector
  • Richard W. WagnerDirector
  • William WexlerDirector
  • Sandra GurrolaExecutive Officer
Offering amount
$8.7M
Amount sold
$8.7M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.7MraisedDec 2022 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew JacksonExecutive Officer
  • William WexlerDirector
  • Matthew AngelDirector, Executive Officer
  • Gregory FioreDirector
  • Nicholas J. SingerDirector
  • Charles CheringtonDirector
  • Sandra GurrolaExecutive Officer
  • Roger SidhuExecutive Officer
Offering amount
$7.7M
Amount sold
$7.7M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedMar 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandra GurrolaExecutive Officer
  • Erin S. EnrightDirector
  • Kevin D'AmourExecutive Officer
  • Roger SidhuExecutive Officer
  • Erich MohrDirector
  • Charles CheringtonDirector
  • Howard J. FederoffExecutive Officer, Director
  • Jay SialExecutive Officer
  • Dennis LangerDirector
  • Heather B. RedmanDirector
Offering amount
$12M
Amount sold
$12M
Sales commissions
$900K
Placement agents
Cantor Fitzgerald & Co., Maxim Group LLC
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.